 | • レポートコード：MRC2-11QY12655 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は代謝バイオマーカー検査のグローバル市場について調査・分析したレポートです。種類別（分離技術、検出技術、その他）市場規模、用途別（創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別代謝バイオマーカー検査の競争状況、市場シェア ・世界の代謝バイオマーカー検査市場：種類別市場規模 2015年-2020年（分離技術、検出技術、その他） ・世界の代謝バイオマーカー検査市場：種類別市場規模予測 2021年-2026年（分離技術、検出技術、その他） ・世界の代謝バイオマーカー検査市場：用途別市場規模 2015年-2020年（創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス） ・世界の代謝バイオマーカー検査市場：用途別市場規模予測 2021年-2026年（創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス） ・北米の代謝バイオマーカー検査市場分析：米国、カナダ ・ヨーロッパの代謝バイオマーカー検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの代謝バイオマーカー検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の代謝バイオマーカー検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの代謝バイオマーカー検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Agilent Technologies、Bio-Rad Laboratories、Bruker、Danaher、Waters Corporation、Thermo Fisher Scientific、Biocrates Life Sciences、Human Metabolome Technologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
Market Analysis and Insights: Global Metabolic Biomarker Testing Market
The global Metabolic Biomarker Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Metabolic Biomarker Testing Scope and Market Size
Metabolic Biomarker Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabolic Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Market segment by Type, the product can be split into
Separation Techniques
Detection Techniques
Others
Market segment by Application, split into
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue
1.4 Market by Type
1.4.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Separation Techniques
1.4.3 Detection Techniques
1.4.4 Others
1.5 Market by Application
1.5.1 Global Metabolic Biomarker Testing Market Share by Application: 2020 VS 2026
1.5.2 Drug Discovery
1.5.3 Nutrigenomics
1.5.4 Toxicology Testing
1.5.5 Personalized Medicine
1.5.6 Functional Genomics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Metabolic Biomarker Testing Market Perspective (2015-2026)
2.2 Global Metabolic Biomarker Testing Growth Trends by Regions
2.2.1 Metabolic Biomarker Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metabolic Biomarker Testing Historic Market Share by Regions (2015-2020)
2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metabolic Biomarker Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Metabolic Biomarker Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Metabolic Biomarker Testing Players by Market Size
3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2015-2020)
3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metabolic Biomarker Testing Market Concentration Ratio
3.2.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2019
3.3 Metabolic Biomarker Testing Key Players Head office and Area Served
3.4 Key Players Metabolic Biomarker Testing Product Solution and Service
3.5 Date of Enter into Metabolic Biomarker Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metabolic Biomarker Testing Historic Market Size by Type (2015-2020)
4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Metabolic Biomarker Testing Market Size by Application (2015-2020)
5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Metabolic Biomarker Testing Market Size (2015-2020)
6.2 Metabolic Biomarker Testing Key Players in North America (2019-2020)
6.3 North America Metabolic Biomarker Testing Market Size by Type (2015-2020)
6.4 North America Metabolic Biomarker Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Metabolic Biomarker Testing Market Size (2015-2020)
7.2 Metabolic Biomarker Testing Key Players in Europe (2019-2020)
7.3 Europe Metabolic Biomarker Testing Market Size by Type (2015-2020)
7.4 Europe Metabolic Biomarker Testing Market Size by Application (2015-2020)
8 China
8.1 China Metabolic Biomarker Testing Market Size (2015-2020)
8.2 Metabolic Biomarker Testing Key Players in China (2019-2020)
8.3 China Metabolic Biomarker Testing Market Size by Type (2015-2020)
8.4 China Metabolic Biomarker Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Metabolic Biomarker Testing Market Size (2015-2020)
9.2 Metabolic Biomarker Testing Key Players in Japan (2019-2020)
9.3 Japan Metabolic Biomarker Testing Market Size by Type (2015-2020)
9.4 Japan Metabolic Biomarker Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Metabolic Biomarker Testing Market Size (2015-2020)
10.2 Metabolic Biomarker Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metabolic Biomarker Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Metabolic Biomarker Testing Market Size by Application (2015-2020)
11 India
11.1 India Metabolic Biomarker Testing Market Size (2015-2020)
11.2 Metabolic Biomarker Testing Key Players in India (2019-2020)
11.3 India Metabolic Biomarker Testing Market Size by Type (2015-2020)
11.4 India Metabolic Biomarker Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Metabolic Biomarker Testing Market Size (2015-2020)
12.2 Metabolic Biomarker Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Metabolic Biomarker Testing Market Size by Type (2015-2020)
12.4 Central & South America Metabolic Biomarker Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent Technologies
13.1.1 Agilent Technologies Company Details
13.1.2 Agilent Technologies Business Overview
13.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction
13.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2015-2020))
13.1.5 Agilent Technologies Recent Development
13.2 Bio-Rad Laboratories
13.2.1 Bio-Rad Laboratories Company Details
13.2.2 Bio-Rad Laboratories Business Overview
13.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction
13.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2015-2020)
13.2.5 Bio-Rad Laboratories Recent Development
13.3 Bruker
13.3.1 Bruker Company Details
13.3.2 Bruker Business Overview
13.3.3 Bruker Metabolic Biomarker Testing Introduction
13.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2015-2020)
13.3.5 Bruker Recent Development
13.4 Danaher
13.4.1 Danaher Company Details
13.4.2 Danaher Business Overview
13.4.3 Danaher Metabolic Biomarker Testing Introduction
13.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2015-2020)
13.4.5 Danaher Recent Development
13.5 Waters Corporation
13.5.1 Waters Corporation Company Details
13.5.2 Waters Corporation Business Overview
13.5.3 Waters Corporation Metabolic Biomarker Testing Introduction
13.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2015-2020)
13.5.5 Waters Corporation Recent Development
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Details
13.6.2 Thermo Fisher Scientific Business Overview
13.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction
13.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2015-2020)
13.6.5 Thermo Fisher Scientific Recent Development
13.7 Biocrates Life Sciences
13.7.1 Biocrates Life Sciences Company Details
13.7.2 Biocrates Life Sciences Business Overview
13.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction
13.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2015-2020)
13.7.5 Biocrates Life Sciences Recent Development
13.8 Human Metabolome Technologies
13.8.1 Human Metabolome Technologies Company Details
13.8.2 Human Metabolome Technologies Business Overview
13.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction
13.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2015-2020)
13.8.5 Human Metabolome Technologies Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Metabolic Biomarker Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Metabolic Biomarker Testing Revenue
Table 3. Ranking of Global Top Metabolic Biomarker Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metabolic Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Separation Techniques
Table 6. Key Players of Detection Techniques
Table 7. Key Players of Others
Table 8. Global Metabolic Biomarker Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Metabolic Biomarker Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Metabolic Biomarker Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Metabolic Biomarker Testing Market Share by Regions (2015-2020)
Table 12. Global Metabolic Biomarker Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Metabolic Biomarker Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Metabolic Biomarker Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key Metabolic Biomarker Testing Players
Table 19. Global Metabolic Biomarker Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Metabolic Biomarker Testing Market Share by Players (2015-2020)
Table 21. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Biomarker Testing as of 2019)
Table 22. Global Metabolic Biomarker Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Metabolic Biomarker Testing Product Solution and Service
Table 25. Date of Enter into Metabolic Biomarker Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Metabolic Biomarker Testing Market Size Share by Type (2015-2020)
Table 29. Global Metabolic Biomarker Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Metabolic Biomarker Testing Market Size Share by Application (2015-2020)
Table 31. Global Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Metabolic Biomarker Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Metabolic Biomarker Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Metabolic Biomarker Testing Market Share (2019-2020)
Table 35. North America Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Metabolic Biomarker Testing Market Share by Type (2015-2020)
Table 37. North America Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Metabolic Biomarker Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players Metabolic Biomarker Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Metabolic Biomarker Testing Market Share (2019-2020)
Table 41. Europe Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Metabolic Biomarker Testing Market Share by Type (2015-2020)
Table 43. Europe Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Metabolic Biomarker Testing Market Share by Application (2015-2020)
Table 45. China Key Players Metabolic Biomarker Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Metabolic Biomarker Testing Market Share (2019-2020)
Table 47. China Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China Metabolic Biomarker Testing Market Share by Type (2015-2020)
Table 49. China Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China Metabolic Biomarker Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players Metabolic Biomarker Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Metabolic Biomarker Testing Market Share (2019-2020)
Table 53. Japan Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Metabolic Biomarker Testing Market Share by Type (2015-2020)
Table 55. Japan Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Metabolic Biomarker Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Metabolic Biomarker Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Metabolic Biomarker Testing Market Share (2019-2020)
Table 59. Southeast Asia Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Metabolic Biomarker Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Metabolic Biomarker Testing Market Share by Application (2015-2020)
Table 63. India Key Players Metabolic Biomarker Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Metabolic Biomarker Testing Market Share (2019-2020)
Table 65. India Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India Metabolic Biomarker Testing Market Share by Type (2015-2020)
Table 67. India Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India Metabolic Biomarker Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Metabolic Biomarker Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Metabolic Biomarker Testing Market Share (2019-2020)
Table 71. Central & South America Metabolic Biomarker Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Metabolic Biomarker Testing Market Share by Type (2015-2020)
Table 73. Central & South America Metabolic Biomarker Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Metabolic Biomarker Testing Market Share by Application (2015-2020)
Table 75. Agilent Technologies Company Details
Table 76. Agilent Technologies Business Overview
Table 77. Agilent Technologies Product
Table 78. Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 79. Agilent Technologies Recent Development
Table 80. Bio-Rad Laboratories Company Details
Table 81. Bio-Rad Laboratories Business Overview
Table 82. Bio-Rad Laboratories Product
Table 83. Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 84. Bio-Rad Laboratories Recent Development
Table 85. Bruker Company Details
Table 86. Bruker Business Overview
Table 87. Bruker Product
Table 88. Bruker Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 89. Bruker Recent Development
Table 90. Danaher Company Details
Table 91. Danaher Business Overview
Table 92. Danaher Product
Table 93. Danaher Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 94. Danaher Recent Development
Table 95. Waters Corporation Company Details
Table 96. Waters Corporation Business Overview
Table 97. Waters Corporation Product
Table 98. Waters Corporation Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 99. Waters Corporation Recent Development
Table 100. Thermo Fisher Scientific Company Details
Table 101. Thermo Fisher Scientific Business Overview
Table 102. Thermo Fisher Scientific Product
Table 103. Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 104. Thermo Fisher Scientific Recent Development
Table 105. Biocrates Life Sciences Company Details
Table 106. Biocrates Life Sciences Business Overview
Table 107. Biocrates Life Sciences Product
Table 108. Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 109. Biocrates Life Sciences Recent Development
Table 110. Human Metabolome Technologies Business Overview
Table 111. Human Metabolome Technologies Product
Table 112. Human Metabolome Technologies Company Details
Table 113. Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2015-2020) (Million US$)
Table 114. Human Metabolome Technologies Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolic Biomarker Testing Market Share by Type: 2020 VS 2026
Figure 2. Separation Techniques Features
Figure 3. Detection Techniques Features
Figure 4. Others Features
Figure 5. Global Metabolic Biomarker Testing Market Share by Application: 2020 VS 2026
Figure 6. Drug Discovery Case Studies
Figure 7. Nutrigenomics Case Studies
Figure 8. Toxicology Testing Case Studies
Figure 9. Personalized Medicine Case Studies
Figure 10. Functional Genomics Case Studies
Figure 11. Metabolic Biomarker Testing Report Years Considered
Figure 12. Global Metabolic Biomarker Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Metabolic Biomarker Testing Market Share by Regions: 2020 VS 2026
Figure 14. Global Metabolic Biomarker Testing Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Metabolic Biomarker Testing Market Share by Players in 2019
Figure 17. Global Top Metabolic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Biomarker Testing as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Metabolic Biomarker Testing Revenue in 2019
Figure 19. North America Metabolic Biomarker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Metabolic Biomarker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Metabolic Biomarker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Metabolic Biomarker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Metabolic Biomarker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Metabolic Biomarker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Metabolic Biomarker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
代謝検査ソリューションの世界市場（～2026年） Metabolism is a set of chemical processes that takes place in a body to maintain its living state. Metabolic rates varies from person to person and depends upon the gender, height, weight, age, muscle to fat ratios, and the current physical rate of activity. Metabolic testing devices are used to fin…- 毒性検査の世界市場（～2026年） The toxicology testing market includes safety assessment of chemicals, drugs, cosmetic products, food additives, etc, without using animals as test models. This testing is performed on advance cell and tissue models to determine safety by studying the potential of the test substances to cause toxici…
- ADME毒性試験の世界市場（～2026年） ADME testing refers to the pharmacokinetic testing of a compound in living organism and known as ADME/Tox. Drug development is a cost and time intensive process. The traditional drug development process includes toxicity and efficacy testing in in-vivo environment which is responsible for late stage…
- 診断バイオマーカーの世界市場（～2026年） Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various pur…
- メタボロミクスバイオマーカーの世界市場（～2026年） Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms. Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantl…